Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Revvity to Acquire Human Cell Design

Revvity to Acquire Human Cell Design

MT newswireMT newswire2026/09/09 10:49
06:49 AM EDT, 09/09/2026 (MT Newswires) -- Revvity (RVTY) has agreed to acquire Human Cell Design (HCD), the company said Wednesday. Financial terms were not disclosed. The acquisition is expected to bolster Revvity's Life Sciences portfolio, including GLP-1 therapies, the companies said. The deal is expected to close in Q4 2026 pending closing conditions and regulatory approvals.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!